← Leaderboards
Gabi Kastenmuller
Duke University
$6,046,578
Attributed
$19,438,271
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.5M · FY2017–22$10M$7.5M$5M$2.5M$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$19,438,271 · 3
By mechanism
U01$10,041,090 · 1
RF1$9,397,181 · 2
Top collaborators
- Rima F Kaddurah-Daouk10 shared
- Cornelia Marja Van Duijn7 shared
- Roberta Diaz Brinton1 shared
- Rui Chang1 shared
- Nathan D Price1 shared
Most similar at Duke University
Same institution · by research overlap
- Rima F Kaddurah-Daouk$56,438,861
- Cornelia Marja Van Duijn$4,935,431
- Tereza Martinu$936,754
- Sheila Collins$15,347,398
- Emilio Alberto Parrado$3,389,844
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposMetabolicBrainNetwork ModelsSamplingCohortDrug DevelopmentInsightMetabolomicsMolecularDatabasesGenotypeAtlasesDrug DiscoveryLinkCommunitiesBiochemicalFailurePathway InteractionsClassificationCholesterolDiabetes MellitusDisease PhenotypeGut Microbiome
Grant awards (10)
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$1,928,443
U01 · FY2022 · AG
Characterizing the AD Metabolome in Brain Tissue Samples of Individuals from Diverse Populations$1,255,605
U01 · FY2022 · AG
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$346,752
U01 · FY2022 · AG
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$1,619,858
U01 · FY2021 · AG
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$1,604,844
U01 · FY2020 · AG
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$125,041
U01 · FY2020 · AG
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$1,501,317
U01 · FY2019 · AG
Metabolic Networks and Pathways Predictive of Sex Differences in AD Risk and Responsiveness to Treatment$5,887,658
RF1 · FY2018 · AG
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$1,659,230
U01 · FY2018 · AG
Metabolic Network Analysis of Biochemical Trajectories in Alzheimer's Disease$3,509,523
RF1 · FY2017 · AG